Sun Pharma Acquires Innovcare Lifesciences for $28.7 Million

On June 20, 2026, Sun Pharmaceutical Industries announced it will acquire 100% of Innovcare Lifesciences in a deal valued at approximately $28.73 million. The transaction, equivalent to about 2.71 billion Indian rupees, will see Sun Pharma take full ownership of the company, marking a notable consolidation in the Indian pharmaceutical sector.

Sun Pharma acquisition deal

• ▪The acquisition of Innovcare Lifesciences by Sun Pharmaceutical Industries was announced on June 20, 2026
• ▪Sun Pharmaceutical Industries announced it will acquire 100% of Innovcare Lifesciences

Transaction financial terms

• ▪The acquisition deal is valued at approximately 2.71 billion Indian rupees
• ▪The exchange rate used for the transaction's valuation was $1 to 94.3200 Indian rupees
• ▪The value of the acquisition deal is approximately $28.73 million